证券代码：688166 证券简称：博瑞医药 公告编号：2025-033 转债代码：118004 转债简称：博瑞转债

Group 1 - The company has announced a cash dividend distribution plan for the year 2024, approving a distribution of 0.96 yuan per 10 shares to all shareholders [2] - The dividend distribution will not include capital reserve transfers or bonus shares, and any changes in the total share capital before the distribution date will lead to adjustments in the total distribution amount [2] - The company will adjust the conversion price of "Bright Convertible Bonds" in accordance with the relevant regulations after the implementation of the dividend distribution plan [2] Group 2 - The trading of "Bright Convertible Bonds" will be suspended from June 12, 2025, until the equity distribution registration date, with resumption of trading on the first trading day after the registration date [3] - The company will disclose the implementation announcement of the equity distribution, the adjustment of the conversion price for "Bright Convertible Bonds," and the total cash dividend amount on June 13, 2025 [3] - Holders of convertible bonds wishing to enjoy the dividend distribution must convert their bonds before June 11, 2025 [3]